Can Fite Biopharma
CANF
#9761
Rank
NZ$22.05 M
Marketcap
$3.36
Share price
-1.99%
Change (1 day)
-4.91%
Change (1 year)

Revenue for Can Fite Biopharma (CANF)

Revenue in 2023 (TTM): NZ$1.2 Million

According to Can Fite Biopharma 's latest financial reports the company's current revenue (TTM ) is NZ$1.26 Million. a decrease over the revenue in the year 2022 that were of NZ$1.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Can Fite Biopharma from 2011 to 2023

Annual revenue

Year Revenue Change
2023 NZ$1.17 M-7.91%
2022 NZ$1.27 M2.16%
2021 NZ$1.24 M18.1%
2020 NZ$1.05 M-64.95%
2019 NZ$3.01 M-47.02%
2018 NZ$5.69 M381.88%
2017 NZ$1.18 M382.97%
2016 NZ$0.24 M1.68%
2015 NZ$0.24 M
2014 N/A
2013 N/A
2012 N/A-100%
2011 NZ$0.62 M